tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SPRY Stock Latest News

ARS Pharmaceuticals: Strong Market Position and Growth Potential Justify Buy Rating
RatingsARS Pharmaceuticals: Strong Market Position and Growth Potential Justify Buy Rating
6d ago
SPRY
ARS Pharmaceuticals Reports Strong Growth for neffy
PremiumCompany Announcements
ARS Pharmaceuticals Reports Strong Growth for neffy
12d ago
SPRY
ARS Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany Announcements
ARS Pharmaceuticals Reports Q2 2025 Financial Results
13d ago
8K
SPRY
ARS Pharmaceuticals sees cash runway for at least next three years
PremiumThe Fly
ARS Pharmaceuticals sees cash runway for at least next three years
13d ago
SPRY
ARS Pharmaceuticals reports reports Q2 EPS (46c), consensus (51c)
PremiumThe Fly
ARS Pharmaceuticals reports reports Q2 EPS (46c), consensus (51c)
13d ago
SPRY
Ars Pharmaceuticals, Inc. (SPRY) Q2 Earnings Cheat Sheet
PremiumPre-EarningsArs Pharmaceuticals, Inc. (SPRY) Q2 Earnings Cheat Sheet
15d ago
SPRY
ARS Pharmaceuticals announces UK MHRA approval of EURneffy
Premium
The Fly
ARS Pharmaceuticals announces UK MHRA approval of EURneffy
1M ago
SPRY
ARS Pharmaceuticals Holds 2025 Annual Stockholders Meeting
Premium
Company Announcements
ARS Pharmaceuticals Holds 2025 Annual Stockholders Meeting
2M ago
8K
SPRY
Ars Pharmaceuticals’ Neffy Launch Boosts Market Prospects
PremiumCompany Announcements
Ars Pharmaceuticals’ Neffy Launch Boosts Market Prospects
3M ago
SPRY
ARS Pharmaceuticals Reports Strong Q1 2025 Performance
PremiumCompany Announcements
ARS Pharmaceuticals Reports Strong Q1 2025 Performance
3M ago
SPRY
Morning Movers: Sony and Dynatrace jump following earnings
PremiumThe Fly
Morning Movers: Sony and Dynatrace jump following earnings
3M ago
DT
ARCO
ARS Pharmaceuticals reports Q1 EPS (35c), consensus (36c)
PremiumThe Fly
ARS Pharmaceuticals reports Q1 EPS (35c), consensus (36c)
3M ago
SPRY
ARS Pharmaceuticals’ neffy 1mg now available across U.S.
PremiumThe FlyARS Pharmaceuticals’ neffy 1mg now available across U.S.
4M ago
SPRY
ARS Pharmaceuticals: Strategic Partnership and Market Expansion Drive Buy Rating
Premium
Ratings
ARS Pharmaceuticals: Strategic Partnership and Market Expansion Drive Buy Rating
4M ago
SPRY
ARS Pharmaceuticals Air Lease ALK-Abello
Premium
The Fly
ARS Pharmaceuticals Air Lease ALK-Abello
4M ago
SPRY
ARS Pharmaceuticals: Strategic Growth and Market Penetration Justify Buy Rating
PremiumRatings
ARS Pharmaceuticals: Strategic Growth and Market Penetration Justify Buy Rating
5M ago
SPRY
ARS Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
ARS Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
5M ago
SPRY
ARS Pharmaceuticals Reports Strong 2024 Financial Results
PremiumCompany Announcements
ARS Pharmaceuticals Reports Strong 2024 Financial Results
5M ago
SPRY
Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz
PremiumThe Fly
Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz
5M ago
YY
ACN
ARS Pharmaceuticals: Strong Market Performance and Strategic Advancements Drive Buy Rating
PremiumRatingsARS Pharmaceuticals: Strong Market Performance and Strategic Advancements Drive Buy Rating
5M ago
SPRY
ARS Pharmaceuticals expects cash to fund operations for at least next 3 years
Premium
The Fly
ARS Pharmaceuticals expects cash to fund operations for at least next 3 years
5M ago
SPRY
ARS Pharmaceuticals reports FY24 EPS 8c, consensus (56c)
Premium
The Fly
ARS Pharmaceuticals reports FY24 EPS 8c, consensus (56c)
5M ago
SPRY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >